NewHydrogen (NEWH) 10-K 4 Mar 16 2015 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2015	Mar. 03, 2016	Jun. 30, 2015
Document and Entity Information:
Entity Registrant Name	BioSolar Inc
Entity Central Index Key	1,371,128
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Type	10-K
Document Period End Date	Dec. 31, 2015
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2,015
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Filer Category	Smaller Reporting Company
Entity Current Reporting Status	Yes
Entity Public Float			$ 4,247,414
Entity Common Stock, Shares Outstanding		18,848,307

Balance Sheets

Balance Sheets - USD ($)	Dec. 31, 2015	Dec. 31, 2014
CURRENT ASSETS
Cash	$ 202,610	$ 146,640
Prepaid expenses	86,943	45,620
TOTAL CURRENT ASSETS	289,553	192,260
PROPERTY AND EQUIPMENT
Machinery and equipment	28,855	82,635
Less accumulated depreciation	(17,326)	(50,937)
NET PROPERTY AND EQUIPMENT	11,529	31,698
OTHER ASSETS
Patents	70,270	85,830
Deposit	770	770
TOTAL OTHER ASSETS	71,040	86,600
TOTAL ASSETS	372,122	310,558
CURRENT LIABILITIES
Accounts payable	2,055	6,982
Accrued expenses	110,676	35,272
Derivative liability	7,878,599	3,320,943
Related party convertible promissory notes net of debt discount of $46,354 and $91,341, respectively	138,646	223,659
Convertible promissory notes net of debt discount of $232,645 and $216,263, respectively	966,855	308,737
TOTAL CURRENT LIABILITIES	$ 9,096,831	$ 3,895,593
SHAREHOLDERS' DEFICIT
Preferred stock, $0.0001 par value; 10,000,000 authorized common shares
Common stock, $0.0001 par value; 500,000,000 authorized common shares 17,995,953 and 11,846,354 shares issued and outstanding, respectively	$ 1,799	$ 1,184
Additional paid in capital	7,474,644	6,822,815
Accumulated deficit	(16,201,152)	(10,409,034)
TOTAL SHAREHOLDERS' DECIFIT	(8,724,709)	(3,585,035)
TOTAL LIABILITIES AND SHAREHOLDERS' DEFICIT	$ 372,122	$ 310,558

Balance Sheets (Parenthetical)

Balance Sheets (Parenthetical) - USD ($)	Dec. 31, 2015	Dec. 31, 2014
Statement of Financial Position [Abstract]
Related party convertible promissory notes, debt discount	$ 46,354	$ 91,341
Convertible promissory notes, debt discount	$ 232,645	$ 216,263
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	10,000,000	10,000,000
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	500,000,000	500,000,000
Common stock, shares issued	17,995,953	11,846,354
Common stock, shares outstanding	17,995,953	11,846,354

Statements of Operations

Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Income Statement [Abstract]
REVENUE
OPERATING EXPENSES
General and administrative expenses	$ 920,548	$ 513,730
Research and development	190,565	69,809
Depreciation and amortization	6,772	7,941
TOTAL OPERATING EXPENSES	1,117,885	591,480
LOSS FROM OPERATIONS BEFORE OTHER INCOME	(1,117,885)	(591,480)
TOTAL OTHER INCOME/(EXPENSES)
Interest income	46	$ 30
Loss on abandoned assets	(1,018)
Gain on sale of equipment	9,862
Fair value of debt financing cost	(66,976)
Loss on change in derivative liability	(4,086,512)	$ (2,645,222)
Interest expense	(529,635)	(193,507)
TOTAL OTHER INCOME/(EXPENSES)	(4,674,233)	(2,838,699)
NET INCOME (LOSS)	$ (5,792,118)	$ (3,430,179)
BASIC AND DILUTED LOSS PER SHARE	$ (0.37)	$ (0.33)
WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING BASIC AND DILUTED	15,599,745	10,411,873

Statement of Shareholders' Defi

Statement of Shareholders' Deficit - USD ($)	Total	Preferred Stock	Common Stock	Additional Paid-in Capital	Accumulated Deficit
Beginning balance at Dec. 31, 2013	$ (352,739)		$ 904	$ 6,625,212	$ (6,978,855)
Beginning balance, Shares at Dec. 31, 2013			9,041,281
Issuance of common shares for converted promissory notes	146,000		$ 280	$ 145,720
Issuance of common shares for converted promissory notes, Shares			2,805,073
Stock based compensation	51,883			$ 51,883
Net Loss	(3,430,179)				$ (3,430,179)
Ending balance at Dec. 31, 2014	(3,585,035)		$ 1,184	$ 6,822,815	$ (10,409,034)
Ending balance, Shares at Dec. 31, 2014			11,846,354
Issuance of common shares for converted promissory notes	206,148		$ 615	$ 205,533
Issuance of common shares for converted promissory notes, Shares			6,149,599
Stock based compensation	446,296			$ 446,296
Net Loss	(5,792,118)				$ (5,792,118)
Ending balance at Dec. 31, 2015	$ (8,724,709)		$ 1,799	$ 7,474,644	$ (16,201,152)
Ending balance, Shares at Dec. 31, 2015			17,995,953

Statements of Cash Flows

Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (5,792,118)	$ (3,430,179)
Adjustment to reconcile net loss to net cash used in operating activities
Depreciation and amortization expense	6,772	7,941
Stock based compensation	446,296	51,883
Loss on conversion of debt and change in derivative liability	4,086,512	$ 2,645,222
Fair value of financing cost	66,976
Amortization of debt discount recognized as interest expense	432,774	$ 159,874
Gain on sale of asset	(9,862)
Loss on abandoned assets	1,018
(Increase) Decrease in:
Prepaid expenses	(41,323)	$ (37,317)
Other assets	24,850
Increase (Decrease) in:
Accounts payable	(4,927)	$ 6,317
Accrued expenses	96,050	124,125
NET CASH USED IN OPERATING ACTIVITIES	(686,982)	(472,134)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of equipment	(759)	$ (844)
Proceeds from sale of asset	23,000
Patent expenditures	(9,289)	$ (38,732)
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES	12,952	(39,576)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from convertible promissory notes	730,000	500,000
NET CASH PROVIDED BY FINANCING ACTIVITIES	730,000	500,000
NET INCREASE/(DECREASE) IN CASH	55,970	(11,710)
CASH, BEGINNING OF PERIOD	146,640	158,350
CASH, END OF PERIOD	202,610	146,640
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Interest paid	$ 809	$ 529
Taxes paid
SUPPLEMENTAL SCHEDULE OF NON-CASH TRANSACTIONS
Common stock issued for convertible notes and accrued interest	$ 206,148	$ 146,000
Accrued salaries exchanged for promissory notes		$ 128,000

Organization and Line of Busine

Organization and Line of Business	12 Months Ended
	Dec. 31, 2015
Organization and Line of Business [Abstract]
ORGANIZATION AND LINE OF BUSINESS	1. ORGANIZATION AND LINE OF BUSINESS Organization BioSolar, Inc. (the "Company") was incorporated in the state of Nevada on April 24, 2006. The Company, based in Santa Clarita, California, began operations on April 25, 2006 to develop and market Photovoltaic solar technology products. Line of Business We are engaged in the development of innovative technologies and materials that will reduce the cost per watt of electricity generated by Photovoltaic solar modules. We have developed BioBacksheet TM Going Concern The accompanying financial statements have been prepared on a going concern basis of accounting, which contemplates continuity of operations, realization of assets and liabilities and commitments in the normal course of business. The accompanying financial statements do not reflect any adjustments that might result if the Company is unable to continue as a going concern. The Company has not generated significant revenue, and has negative cash flows from operations, which raise substantial doubt about the Company’s ability to continue as a going concern. The ability of the Company to continue as a going concern and appropriateness of using the going concern basis is dependent upon, among other things, additional cash infusion. The Company has historically obtained funds through private placements offerings of equity and debt. Management believes that it will be able to continue to raise funds through the sale of its securities to its existing shareholders and prospective new investors which will provide the additional cash needed to meet the Company’s obligations as they become due, and riallow the development of its core of business There is no assurance that the Company will be able to continue raising the required capital for its operations.

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2015
Summary of Significant Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES This summary of significant accounting policies of the Company are presented to assist in understanding the Company’s financial statements. The financial statements and notes are representations of the Company’s management, which is responsible for their integrity and objectivity. These accounting policies conform to accounting principles generally accepted in the United States of America and have been consistently applied in the preparation of the financial statements. Revenue Recognition The Company will recognize revenue when services are performed, and at the time of shipment of products, provided that evidence of an arrangement exists, title and risk of loss have passed to the customer, fees are fixed or determinable, and collection of the related receivable is reasonably assured. To date, the Company has not had significant revenues and is in the development stage. Cash and Cash Equivalent The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the accompanying financial statements. Significant estimates made in preparing these financial statements include the estimate of useful lives of property and equipment, the deferred tax valuation allowance, derivative liabilities and the fair value of stock options. Actual results could differ from those estimates. Intangible Assets Intangible assets consist of patents that are initially measured at the lower of cost or fair value. The patents are deemed to have an indefinite life and are not amortized. The patents are assessed annually for impairment, or whenever conditions indicate the asset may be impaired, and any such impairment will be recognized in the period identified. Property and Equipment Property and equipment are stated at cost, and are depreciated using straight line over its estimated useful lives: Computer equipment 5 Years Machinery & equipment 10 Years Depreciation expense for the years ended December 31, 2015 and 2014 was $6,772 and $7,941, respectively. Research and Development Research and development costs are expensed as incurred. Total research and development costs were $190,565 and $69,809 for the years ended December 31, 2015 and 2014, respectively. Stock-Based Compensation The Company measures the cost of employee services received in exchange for an equity award based on the grant-date fair value of the award. All grants under our stock-based compensation programs are accounted for at fair value and that cost is recognized over the period during which an employee, consultant, or director are required to provide service in exchange for the award (the vesting period). Compensation expense for options granted to employees and non-employees is determined in accordance with the standard as the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measured. Compensation expense for awards granted is re-measured each period. Determining the appropriate fair value of the stock-based compensation requires the input of subjective assumptions, including the expected life of the stock-based payment and stock price volatility. The Company uses the Black-Scholes option-pricing model to value its stock option awards which incorporate the Company’s stock price, volatility, U.S. risk-free rate, dividend rate, and estimated life. On March 24, 2015, the Company granted 2,450,000 stock options with an exercise price of $0.09 per share, and on September 2, 2015 the Company granted an additional 13,500,000 stock options with an exercise price of $0.26 per share. The options will vest 1/25 on a monthly basis starting April 24, 2015 and October 1, 2015, respectively, and terminate seven (7) years from the date of grant or upon termination of employment. Income Taxes Deferred income taxes are provided using the liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carry-forwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of the changes in tax laws and rates of the date of enactment. When tax returns are filed, it is highly certain that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. The benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above is reflected as a liability for unrecognized tax benefits in the accompanying balance sheet along with any associated interest and penalties that would be payable to the taxing authorities upon examination. Income (Loss) per Share Calculations Loss per Share dictates the calculation of basic earnings per share and diluted earnings per share are computed by dividing income available to common shareholders by the weighted-average number of common shares available. Diluted earnings per share is computed similar to basic earnings per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. The Company’s diluted loss per share is the same as the basic loss per share for the year ended December 31, 2015, as the inclusion of any potential shares would have had an anti-dilutive effect due to the Company generating a loss. The Company has excluded 15,978,333 options, 245,000 warrants, and the shares issuable from convertible debt of $1,384,500 for the year ended December 31, 2015. For the years ended December 31, , 2015 2014 (Loss) to common shareholders (Numerator) $ (5,792,118 ) $ (3,430,179 ) Basic and diluted weighted average number of common shares outstanding (Denominator) 15,599,745 10,411,873 Fair Value of Financial Instruments Fair Value of Financial Instruments, requires disclosure of the fair value information, whether or not recognized in the balance sheet, where it is practicable to estimate that value. As of December 31, 2015, the amounts reported for cash, inventory, prepaid expenses, accounts payable, and accrued expenses, approximate the fair value because of their short maturities. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 established a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include: ● Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. We measure certain finan Total (Level 1) (Level 2) (Level 3) Derivative Liability $ 3,320,943 $ - $ - $ 3,320,943 Total liabilities measured at fair value $ 3,320,943 $ - $ - $ 3,320,943 We measure certain financial instruments at fair value on a recurring basis. Assets and liabilities measured at fair value on a recurring basis are as follows at December 31, 2015: Total (Level 1) (Level 2) (Level 3) Derivative Liability $ 7,878,599 $ - $ - $ 7,878,599 Total liabilities measured at fair value $ 7,878,599 $ - $ - $ 7,878,599 The following is a reconciliation of the derivative liability for which Level 3 inputs were used in determining the approximate fair value: Balance as of December 31, 2013 $ 361,170 Fair value of derivative liabilities issued 314,551 Loss on change in derivative liability 2,645,222 Balance as of December 31, 2014 $ 3,320,943 Fair value of derivative liabilities issued 471,144 Loss on change in derivative liability 4,086,512 Balance as of December 31, 2015 $ 7,878,599 Recently Issued Accounting Pronouncements Management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying condensed financial statements. In August 2014, FASB issued ASU 2014-15, “Presentation of Financial Statements Going Concern (Subtopic 205-40) – Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern”. Currently, there is no guidance in U.S. GAAP about management’s responsibility to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern or to provide related footnote disclosures. The amendments in this ASU provide that guidance. In doing so, the amendments are intended to reduce diversity in the timing and content of footnote disclosures. The amendments require management to assess an entity’s ability to continue as a going concern by incorporating and expanding upon certain principles that are currently in U.S. auditing standards. Specifically, the amendments (1) provide a definition of the term substantial doubt, (2) require an evaluation every reporting period including interim periods, (3) provide principles for considering the mitigating effect of management’s plans, (4) require certain disclosures when substantial doubt is alleviated as a result of consideration of management’s plans, (5) require an express statement and other disclosures when substantial doubt is not alleviated, and (6) require an assessment for a period of one year after the date that the financial statements are issued (or available to be issued). The amendments in this ASU are effective for public and nonpublic entities for annual periods ending after December 15, 2016. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of ASU 2014-15 on the Company’s financial statements.

Capital Stock

Capital Stock	12 Months Ended
	Dec. 31, 2015
Capital Stock [Abstract]
CAPITAL STOCK	3. CAPITAL STOCK During the year ended December 31, 2015, the Company issued 6,149,599 shares of common stock at prices ranging from $0.0133 to $0.065 per share upon conversion of $185,500 in convertible promissory notes, including $20,648 in accrued interest. During the year ended December 31, 2014, the Company issued 2,805,073 shares of common stock at prices ranging from $0.0367 to $0.10, for conversion of $135,000 in convertible promissory notes, including $11,000 in accrued interest.

Stock Options and Warrants

Stock Options and Warrants	12 Months Ended
	Dec. 31, 2015
Stock Options and Warrants [Abstract]
STOCK OPTIONS AND WARRANTS	4. STOCK OPTIONS AND WARRANTS Stock Options During the years ended December 31, 2015 and 2014, respectively, the Company granted 15,950,000 and 0 stock options. 12/31/2015 12/31/2014 Weighted Weighted Number average Number average of exercise of exercise Options price Options price Outstanding, beginning of period 836,667 $ 1.43 836,667 $ 1.43 Granted 15,950,000 0.23 - - Exercised - - - - Expired (808,334 ) 1.45 - - Outstanding, end of period 15,978,333 $ 0.23 836,667 $ 1.43 Exercisable at the end of period 2,530,333 $ 0.21 811,667 $ 1.46 Stock Options The weighted average remaining contractual life of options outstanding as of December 31, 2015 was as follows: Weighted Average Stock Stock Remaining Exercisable Options Options Contractual Prices Outstanding Exercisable Life (years) $ 4.05 3,333 3,333 0.23 2.92 25,000 25,000 2.17 0.09 2,450,000 882,000 6.23 0.26 13,500,000 1,620,000 6.68 Total 15,978,333 2,530,333 The weighted average remaining contractual life of options outstanding as of December 31, 2014 was as follows: Weighted Average Stock Stock Remaining Exercisable Options Options Contractual Prices Outstanding Exercisable Life (years) $ 4.05 236,667 236,667 1.23 0.40 600,000 575,000 3.17 Total 836,667 811,667 The stock-based compensation expense recognized in the statement of operations during the years ended December 31, 2015 and 2014, related to the granting of these options was $446,296 and $51,883, respectively. As of December 31, 2015, there was no intrinsic value with regards to the outstanding options. For purpose of determining the fair market value of the stock options granted during the year ended December 31, 2015, the Company used Black Scholes option valuation model. The significant assumptions used in the Black Scholes valuation of the derivative are as follows: Risk free interest rate 1.68% – 1.92% Stock volatility factor 104.37% - 114.97% Weighted average expected option life 7 years Expected dividend yield None Warrants During the year ended December 31, 2015, the Company granted no warrants. As of December 31, 2015, 245,000 warrants are outstanding. The warrant terms are 5 years with 95,000 warrants expiring in October 2016 and 150,000 warrants expiring in October 2017. December 31, 2015 Weighted Number average of exercise Warrants price Outstanding, January 1, 2015 245,000 $ 0.97 Granted - - Exercised - - Expired - - Outstanding, December 31, 2015 245,000 $ 0.97 Exercisable at the end of period 245,000 $ 0.97

Convertible Promissory Notes

Convertible Promissory Notes	12 Months Ended
	Dec. 31, 2015
Convertible Promissory Notes [Abstract]
CONVERTIBLE PROMISSORY NOTES	5. CONVERTIBLE PROMISSORY NOTES On January 18, 2013, the Company entered into a securities purchase agreement for the sale of a 10% convertible promissory note in the aggregate principal amount of $80,000, to be advanced in amounts at the lender’s discretion. Upon execution of the securities purchase agreement, the Company received an advance of $10,000. On April 16, 2013, the Company received an additional advance of $25,000. The total advances received were $35,000, of which principal in the amount of $25,000, and $2,886 in accrued interest was converted into 183,481 shares of common stock at fair value of $0.43 and $0.367 per share on September 29, 2013 and October 3, 2014. On July 6, 2015 the Company issued 735,153 shares of common stock at a fair value of $0.0133 upon conversion of principal in the amount of $8,000, plus accrued interest of $1,778, leaving a balance of $2,000. During the month of July 2013, the Company extended the maturity date of the note from six (6) months to eighteen (18) months from the effective date of each advance. The note is convertible into shares of common stock of the Company at a price equal to a variable conversion price of the lesser of a) $0.40 per share b) fifty percent (50%) of the lowest trading price of common stock recorded on any trade day after the effective date, or c) the lowest effective price per share granted to any person or entity, after the effective date, to acquire common stock. The fair value of the notes has been determined by using Black-Scholes pricing model with an expected life of more than a year. On March 1, 2013, the Company entered into a securities purchase agreement, providing for the sale by the Company of a 10% unsecured Convertible Note in the aggregate principal amount of $100,000, to be advanced in amounts at the lender’s discretion. The Company received advances of $35,000 during the year ended December 31, 2013. The note was amended on February 24, 2014, and was extended for six (6) months to mature on August 28, 2014. The maturity date was subsequently extended to August 28, 2015. The note is convertible into shares of common stock of the Company at a price equal to a variable conversion price of the lesser of $0.20 per share or fifty percent (50%) of the lowest trading price recorded on any trade day after the effective date. On October 2, 2014 and December 30, 2014, the lender converted $20,000 in principal, plus $11,001 of accrued interest. As of December 31, 2014, the remaining balance was $15,000. On February 25, 2015, the Company issued 325,525 shares of common stock at fair value of $0.0367 for principal in the amount of $10,000, plus accrued interest of $1,939, leaving a remaining balance of $5,000 as of March 31, 2015. On April 21, 2015, the remaining principal of $5,000, plus accrued interest of $1,071 was converted into 182,319 shares of common stock. The fair value of the note has been determined by using the Black-Scholes pricing model with an expected life of less than a year. As of December 31, 2015, the note was fully converted. On May 2, 2014, the Company entered into a securities purchase agreement, providing for the sale by the Company of a 10% unsecured Convertible Note in the aggregate principal amount of $500,000, to be advanced in amounts at the lender’s discretion. Upon execution of the securities purchase agreement, the Company received an advance in the amount of $50,000. On various dates, the Company received additional advances in the aggregate sum of $450,000, for a total aggregate sum of $500,000. During the year ended December 31, 2015, the Company issued 2,718,911 shares of common stock for principal in the amount of $32,500, plus accrued interest of $3,661. The principal balance remaining as of December 31, 2015 was $467,500. The note matures nine months from the effective date of each advance. The note is convertible into shares of common stock of the Company at a price equal to a variable conversion price of a) the lesser of $0.25 per share of common stock, b) fifty percent (50%) of the average three (3) lowest trading prices of three (3) separate trading days recorded after the effective date, or c) the lowest effective price granted to any person or entity after the effective date to acquire common stock. The fair value of the note has been determined by using the Black-Scholes pricing model with an expected life of eighteen (18) months. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $139,656 during the years ended December 31, 2015. On January 30, 2015, the Company entered into a securities purchase agreement, providing for the sale by the Company of a 10% unsecured Convertible Note in the aggregate principal amount of $500,000, to be advanced in amounts at the lender’s discretion. Upon execution of the securities purchase agreement, the Company received an advance in the amount of $50,000. On various dates, the Company received additional advances in the aggregate sum of $450,000. The principal balance at December 31, 2015 was $467,500. The note matures nine months from the effective date of each advance. The note is convertible into shares of common stock of the Company at a price equal to a variable conversion price of a) the lesser of $0.15 per share of common stock, b) fifty percent (50%) of the lowest trade price recorded since the original effective date of the note, or c) the lowest effective price per share granted to any person or entity after the effective date to acquire common stock. The fair value of the note has been determined by using the Black-Scholes pricing model with an expected life of nine (9) months. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $186,290 during the year ended December 31, 2015. On October 1, 2015, the Company entered into a securities purchase agreement, providing for the sale by the Company of a 10% unsecured Convertible Note in the aggregate principal amount of $500,000, to be advanced in amounts at the lender’s discretion. Upon execution of the securities purchase agreement, the Company received an advance in the amount of $90,000. On various dates, the Company received additional advances in the aggregate sum of $140,000. The principal balance at December 31, 2015 was $230,000. The note matures twelve (12) months from the effective date of each advance. The note is convertible into shares of common stock of the Company at a price equal to a variable conversion price of a) the lesser of $0.25 per share of common stock, b) fifty percent (50%) of the lowest trade price recorded since the original effective date of the note, or c) the lowest effective price per share granted to any person or entity after the effective date to acquire common stock. The fair value of the note has been determined by using the Black-Scholes pricing model with an expected life of twelve (12) months. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $20,739 during the year ended December 31, 2015. RELATED PARTY CONVERTIBLE PROMISSORY NOTES On June 5, 2013, the Company issued two 5% convertible promissory notes in exchange for services rendered by the Company’s Chief Executive Officer ($114,000) and Chief Technology Officer ($128,000) in the aggregate amount of $242,000. On March 5, 2014, the Company issued 694,191 upon partial conversion of principal in the amount of $55,000, plus accrued interest of $2,063, leaving a remaining balance of $187,000. On April 17, 2015, the Company issued 2,187,692 shares of common stock upon conversion of $130,000 in principal, plus $12,200 in accrued interest, leaving a balance of $57,000. The notes are convertible into shares of common stock of the Company at a conversion price equal to the lesser of $0.24 per share or the closing price per share of common stock recorded on the trading day immediately preceding the date of conversion. The notes matured two (2) years from their effective dates, and were extended on June 22, 2015 for one (1) year with a maturity date of June 5, 2016. The fair value of the notes has been determined by using the Black-Scholes pricing model with an expected life of two (2) years. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $24,360 during the year ended December 31, 2015. On December 18, 2014, the Company issued two 5% convertible promissory notes in exchange for services rendered by the Company’s Chief Executive Officer ($68,000) and Chief Technology Officer ($61,000) in the aggregate amount of $128,000. The notes are convertible into shares of common stock of the Company at a conversion price equal to the lesser of $0.101 per share of common stock or the closing price per share of common stock recorded on the trading day immediately preceding the date of conversion. The notes mature two (2) years from their effective dates. The fair value of the notes has been determined by using the Black-Scholes pricing model with an expected life of two (2) years. The Company recorded amortization of debt discount, which was recognized as interest expense in the amount of $47,930 during the year ended December 31, 2015. We evaluated the financing transactions in accordance with ASC Topic 815, Derivatives and Hedging, and determined that the conversion feature of the convertible promissory note was not afforded the exemption for conventional convertible instruments due to its variable conversion rate. The note has no explicit limit on the number of shares issuable so they did not meet the conditions set forth in current accounting standards for equity classification. The Company elected to recognize the note under paragraph 815-15-25-4, whereby, there would be a separation into a host contract and derivative instrument. The Company elected to initially and subsequently measure the note in its entirety at fair value, with changes in fair value recognized in earnings. The Company recorded a derivative liability representing the imputed interest associated with the embedded derivative. The derivative liability is adjusted periodically according to the stock price fluctuations.

Derivative Liabilities

Derivative Liabilities	12 Months Ended
	Dec. 31, 2015
Derivative Liabilities [Abstract]
DERIVATIVE LIABILITIES	6. DERIVATIVE LIABILITIES The convertible notes issued and described in Note 5 do not have fixed settlement provisions because their conversion prices are not fixed. The conversion feature has been characterized as derivative liabilities to be re-measured at the end of every reporting period with the change in value reported in the statement of operations. During the year ended December 31, 2015, as a result of the convertible notes issued that were accounted for as derivative liabilities, we determined that the fair value of the conversion feature of the convertible notes at issuance was $471,144, based upon a Black-Sholes-Model calculation. We recorded the full value of the derivative as a liability at issuance with an offset to valuation discount, which will be amortized over the life of the convertible notes. During the year ended December 31, 2015, approximately $185,500 convertible notes were converted. As a result of the conversion of these notes and the change in fair value of the remaining notes, the Company recorded a loss in change in derivative of $4,086,512 in the statement of operations for the year ended December 31, 2015. At December 31, 2015 and 2014, the fair value of the derivative liability was $7,878,599 and $3,320,943, respectively. For purpose of determining the fair market value of the derivative liability for the embedded conversion, the Company used Black Scholes option valuation model. The significant assumptions used in the Black Scholes valuation of the derivatives are as follows: 2015 a 2014 Risk free interest rate 0.00% - 0.64% 0.02% - 0.58% Stock volatility factor 47.60% - 310.4% 104.46% - 149.81% Weighted average expected option life 1 mo - 2 years 6 mos - 2 years Expected dividend yield None None

Intangible Assets

Intangible Assets	12 Months Ended
	Dec. 31, 2015
Intangible Assets [Abstract]
INTANGIBLE ASSETS	7. INTANGIBLE ASSETS The Company has patent applications to protect the inventions and processes behind its proprietary bio-based back-sheet, a protective covering for the back of photovoltaic solar cells traditionally made from petroleum-based film. During the years ended December 31, 2015 and 2014, the Company reviewed the capitalized patents for impairment in accordance with ASC 350, and determined there was no impairment. As of December 31, 2015 and 2013, the carrying value of the patents was $70,270 and $85,830, respectively. As of December 31, 2015 and 2014, no amortization has been expensed for the patents, since approval of the patents are pending.

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2015
Income Taxes [Abstract]
INCOME TAXES	8. INCOME TAXES The Company files income tax returns in the U.S. Federal jurisdiction, and the state of California. With few exceptions, the Company is no longer subject to U.S. federal, state and local, or non-U.S. income tax examinations by tax authorities for years before 2013. Deferred income taxes have been provided by temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for tax purposes. To the extent allowed by GAAP, we provide valuation allowances against the deferred tax assets for amounts when the realization is uncertain. Included in the balances at December 31, 2015 and 2014, are no tax positions for which the ultimate deductibility is highly certain, but for which there is uncertainty about the timing of such deductibility. Because of the impact of deferred tax accounting, other than interest and penalties, the disallowance of the shorter deductibility period would not affect the annual effective tax rate but would accelerate the payment of cash to the taxing authority to an earlier period. The Company's policy is to recognize interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses. During the periods ended December 31, 2015 and 2014, the Company did not recognize interest or penalties. At December 31, 2015, the Company had net operating loss carry-forwards of approximately $7,227,000, which expire starting in 2027. No tax benefit has been reported in the December 31, 2015 and 2014 financial statements, since the potential tax benefit is offset by a valuation allowance of the same amount. The income tax provision differs from the amount of income tax determined by applying the U.S. federal income tax rate to pretax income from continuing operations for the years ended December 31, 2015 and 2014 due to the following: 2015 2014 Book income $ (2,317,510 ) $ (1,372,071 ) Depreciation (730 ) (420 ) Meals and entertainment 370 350 Non-deductible non-cash charges 1,986,900 1,142,791 Accrued payroll - (14,400 ) Valuation Allowance 330,970 243,750 Income tax expense $ - $ - Deferred taxes are provided on a liability method whereby deferred tax assets are recognized for deductible differences and operating loss and tax credit carry-forwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the difference between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. Deferred taxes are provided on a liability method whereby deferred tax assets are recognized for deductible differences and operating loss and tax credit carry-forwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the difference between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. Net deferred tax liabilities consist of the following components as of December 31, 2015 and 2014: 2015 2014 Deferred tax assets: NOL carryover $ 2,614,500 $ 2,299,720 R & D credit 59,250 47,640 Accrued payroll - - Deferred tax liabilites: Depreciation (3,100 ) (7,670 ) Less Valuation Allowance (2,670,650 ) (2,339,690 ) Net deferred tax asset $ - $ - Due to the change in ownership provisions of the Tax Reform Act of 1986, net operating loss carry-forwards for Federal income tax reporting purposes are subject to annual limitations. Should a change in ownership occur, net operating loss carry-forwards may be limited as to use in future years. The Company’s tax returns for the previous three years remain open for audit by the respective tax jurisdictions.

Commitments and Litigations

Commitments and Litigations	12 Months Ended
	Dec. 31, 2015
Commitments and Litigations [Abstract]
COMMITMENTS AND LITIGATIONS	9. COMMITMENTS AND LITIGATIONS The Company’s facility is leased on a month to month basis without an expiration date. Our monthly lease payments were $534, which increased to $550 in November 2015. The rent paid for both years ended December 31, 2015 and 2014 were $6,440 and $6,408, respectively. We are not currently a party to, nor is any of our property currently the subject of, any pending legal proceeding that will have a material adverse effect on our business.

Subsequent Event

Subsequent Event	12 Months Ended
	Dec. 31, 2015
Subsequent Events [Abstract]
SUBSEQUENT EVENT	10. SUBSEQUENT EVENT Management has evaluated subsequent events according to the requirements of ASC TOPIC 855 and has determined that there are the following subsequent events: On January 11, 2016, the Company received $68,000 of additional consideration on a convertible promissory note agreement dated October 1, 2015. On January 11, 2016, the Company revised and restated two (2) convertible notes with original principal sums of up $500,000 issued on May 2, 2014 and January 30, 2015, respectively. The maturity date of the notes was extended to eighteen (18) months from the effective date of each payment of consideration, and is the date upon which the principal sum of each Note and unpaid interest and fees shall be due and payable. On January 15, 2016, the Company issued 660,161 shares of common stock upon conversion of principal in the amount of $7,500, plus accrued interest of $1,280, pertaining to a convertible note issued on May 2, 2014. On January 26, 2016, the Company issued 192,193 shares of common stock upon conversion of principal in the amount of $2,000, plus accrued interest of $556, pertaining to a convertible note issued on July 6, 2015. On February 9, 2016, the Company received $87,000 of additional consideration on a convertible promissory note agreement dated October 1, 2015.

Summary of Significant Accoun17

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2015
Summary of Significant Accounting Policies [Abstract]
Revenue Recognition	Revenue Recognition The Company will recognize revenue when services are performed, and at the time of shipment of products, provided that evidence of an arrangement exists, title and risk of loss have passed to the customer, fees are fixed or determinable, and collection of the related receivable is reasonably assured. To date, the Company has not had significant revenues and is in the development stage.
Cash and Cash Equivalent	Cash and Cash Equivalent The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the accompanying financial statements. Significant estimates made in preparing these financial statements include the estimate of useful lives of property and equipment, the deferred tax valuation allowance, derivative liabilities and the fair value of stock options. Actual results could differ from those estimates.
Intangible Assets	Intangible Assets Intangible assets consist of patents that are initially measured at the lower of cost or fair value. The patents are deemed to have an indefinite life and are not amortized. The patents are assessed annually for impairment, or whenever conditions indicate the asset may be impaired, and any such impairment will be recognized in the period identified.
Property and Equipment	Property and Equipment Property and equipment are stated at cost, and are depreciated using straight line over its estimated useful lives: Computer equipment 5 Years Machinery & equipment 10 Years Depreciation expense for the years ended December 31, 2015 and 2014 was $6,772 and $7,941, respectively.
Research and Development	Research and Development Research and development costs are expensed as incurred. Total research and development costs were $190,565 and $69,809 for the years ended December 31, 2015 and 2014, respectively.
Stock-Based Compensation	Stock-Based Compensation The Company measures the cost of employee services received in exchange for an equity award based on the grant-date fair value of the award. All grants under our stock-based compensation programs are accounted for at fair value and that cost is recognized over the period during which an employee, consultant, or director are required to provide service in exchange for the award (the vesting period). Compensation expense for options granted to employees and non-employees is determined in accordance with the standard as the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measured. Compensation expense for awards granted is re-measured each period. Determining the appropriate fair value of the stock-based compensation requires the input of subjective assumptions, including the expected life of the stock-based payment and stock price volatility. The Company uses the Black-Scholes option-pricing model to value its stock option awards which incorporate the Company’s stock price, volatility, U.S. risk-free rate, dividend rate, and estimated life. On March 24, 2015, the Company granted 2,450,000 stock options with an exercise price of $0.09 per share, and on September 2, 2015 the Company granted an additional 13,500,000 stock options with an exercise price of $0.26 per share. The options will vest 1/25 on a monthly basis starting April 24, 2015 and October 1, 2015, respectively, and terminate seven (7) years from the date of grant or upon termination of employment.
Income Taxes	Income Taxes Deferred income taxes are provided using the liability method whereby deferred tax assets are recognized for deductible temporary differences and operating loss and tax credit carry-forwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the differences between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all of the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of the changes in tax laws and rates of the date of enactment. When tax returns are filed, it is highly certain that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. The benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above is reflected as a liability for unrecognized tax benefits in the accompanying balance sheet along with any associated interest and penalties that would be payable to the taxing authorities upon examination.
Income (Loss) per Share Calculations	Income (Loss) per Share Calculations Loss per Share dictates the calculation of basic earnings per share and diluted earnings per share are computed by dividing income available to common shareholders by the weighted-average number of common shares available. Diluted earnings per share is computed similar to basic earnings per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. The Company’s diluted loss per share is the same as the basic loss per share for the year ended December 31, 2015, as the inclusion of any potential shares would have had an anti-dilutive effect due to the Company generating a loss. The Company has excluded 15,978,333 options, 245,000 warrants, and the shares issuable from convertible debt of $1,384,500 for the year ended December 31, 2015. For the years ended December 31, , 2015 2014 (Loss) to common shareholders (Numerator) $ (5,792,118 ) $ (3,430,179 ) Basic and diluted weighted average number of common shares outstanding (Denominator) 15,599,745 10,411,873
Fair Value of Financial Instruments	Fair Value of Financial Instruments Fair Value of Financial Instruments, requires disclosure of the fair value information, whether or not recognized in the balance sheet, where it is practicable to estimate that value. As of December 31, 2015, the amounts reported for cash, inventory, prepaid expenses, accounts payable, and accrued expenses, approximate the fair value because of their short maturities. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 established a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include: ● Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. We measure certain finan Total (Level 1) (Level 2) (Level 3) Derivative Liability $ 3,320,943 $ - $ - $ 3,320,943 Total liabilities measured at fair value $ 3,320,943 $ - $ - $ 3,320,943 We measure certain financial instruments at fair value on a recurring basis. Assets and liabilities measured at fair value on a recurring basis are as follows at December 31, 2015: Total (Level 1) (Level 2) (Level 3) Derivative Liability $ 7,878,599 $ - $ - $ 7,878,599 Total liabilities measured at fair value $ 7,878,599 $ - $ - $ 7,878,599 The following is a reconciliation of the derivative liability for which Level 3 inputs were used in determining the approximate fair value: Balance as of December 31, 2013 $ 361,170 Fair value of derivative liabilities issued 314,551 Loss on change in derivative liability 2,645,222 Balance as of December 31, 2014 $ 3,320,943 Fair value of derivative liabilities issued 471,144 Loss on change in derivative liability 4,086,512 Balance as of December 31, 2015 $ 7,878,599
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements Management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying condensed financial statements. In August 2014, FASB issued ASU 2014-15, “Presentation of Financial Statements Going Concern (Subtopic 205-40) – Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern”. Currently, there is no guidance in U.S. GAAP about management’s responsibility to evaluate whether there is substantial doubt about an entity’s ability to continue as a going concern or to provide related footnote disclosures. The amendments in this ASU provide that guidance. In doing so, the amendments are intended to reduce diversity in the timing and content of footnote disclosures. The amendments require management to assess an entity’s ability to continue as a going concern by incorporating and expanding upon certain principles that are currently in U.S. auditing standards. Specifically, the amendments (1) provide a definition of the term substantial doubt, (2) require an evaluation every reporting period including interim periods, (3) provide principles for considering the mitigating effect of management’s plans, (4) require certain disclosures when substantial doubt is alleviated as a result of consideration of management’s plans, (5) require an express statement and other disclosures when substantial doubt is not alleviated, and (6) require an assessment for a period of one year after the date that the financial statements are issued (or available to be issued). The amendments in this ASU are effective for public and nonpublic entities for annual periods ending after December 15, 2016. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of ASU 2014-15 on the Company’s financial statements.

Summary of Significant Accoun18

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2015
Summary of Significant Accounting Policies [Abstract]
Schedule of property and equipment	Computer equipment 5 Years Machinery & equipment 10 Years
Schedule of earnings per share, basic and diluted	For the years ended December 31, , 2015 2014 (Loss) to common shareholders (Numerator) $ (5,792,118 ) $ (3,430,179 ) Basic and diluted weighted average number of common shares outstanding (Denominator) 15,599,745 10,411,873
Schedule of assets and liabilities measured at fair value on recurring basis	Total (Level 1) (Level 2) (Level 3) Derivative Liability $ 3,320,943 $ - $ - $ 3,320,943 Total liabilities measured at fair value $ 3,320,943 $ - $ - $ 3,320,943 Total (Level 1) (Level 2) (Level 3) Derivative Liability $ 7,878,599 $ - $ - $ 7,878,599 Total liabilities measured at fair value $ 7,878,599 $ - $ - $ 7,878,599
Schedule of reconciliation of the derivative liability	Balance as of December 31, 2013 $ 361,170 Fair value of derivative liabilities issued 314,551 Loss on change in derivative liability 2,645,222 Balance as of December 31, 2014 $ 3,320,943 Fair value of derivative liabilities issued 471,144 Loss on change in derivative liability 4,086,512 Balance as of December 31, 2015 $ 7,878,599

Stock Options and Warrants (Tab

Stock Options and Warrants (Tables)	12 Months Ended
	Dec. 31, 2015
Stock Options and Warrants [Abstract]
Schedule of stock options activity	12/31/2015 12/31/2014 Weighted Weighted Number average Number average of exercise of exercise Options price Options price Outstanding, beginning of period 836,667 $ 1.43 836,667 $ 1.43 Granted 15,950,000 0.23 - - Exercised - - - - Expired (808,334 ) 1.45 - - Outstanding, end of period 15,978,333 $ 0.23 836,667 $ 1.43 Exercisable at the end of period 2,530,333 $ 0.21 811,667 $ 1.46
Schedule of weighted average remaining contractual life of options outstanding	Weighted Average Stock Stock Remaining Exercisable Options Options Contractual Prices Outstanding Exercisable Life (years) $ 4.05 3,333 3,333 0.23 2.92 25,000 25,000 2.17 0.09 2,450,000 882,000 6.23 0.26 13,500,000 1,620,000 6.68 Total 15,978,333 2,530,333 Weighted Average Stock Stock Remaining Exercisable Options Options Contractual Prices Outstanding Exercisable Life (years) $ 4.05 236,667 236,667 1.23 0.40 600,000 575,000 3.17 Total 836,667 811,667
Schedule of fair market value of the stock options granted using black scholes valuation	Risk free interest rate 1.68% – 1.92% Stock volatility factor 104.37% - 114.97% Weighted average expected option life 7 years Expected dividend yield None
Schedule of warrants	December 31, 2015 Weighted Number average of exercise Warrants price Outstanding, January 1, 2015 245,000 $ 0.97 Granted - - Exercised - - Expired - - Outstanding, December 31, 2015 245,000 $ 0.97 Exercisable at the end of period 245,000 $ 0.97

Derivative Liabilities (Tables)

Derivative Liabilities (Tables)	12 Months Ended
	Dec. 31, 2015
Derivative Liabilities [Abstract]
Schedule of derivative liabilities valuation assumptions	2015 a 2014 Risk free interest rate 0.00% - 0.64% 0.02% - 0.58% Stock volatility factor 47.60% - 310.4% 104.46% - 149.81% Weighted average expected option life 1 mo - 2 years 6 mos - 2 years Expected dividend yield None None

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2015
Income Taxes [Abstract]
Schedule of components of income tax expense	2015 2014 Book income $ (2,317,510 ) $ (1,372,071 ) Depreciation (730 ) (420 ) Meals and entertainment 370 350 Non-deductible non-cash charges 1,986,900 1,142,791 Accrued payroll - (14,400 ) Valuation Allowance 330,970 243,750 Income tax expense $ - $ -
Schedule of deferred tax assets and liabilities	2015 2014 Deferred tax assets: NOL carryover $ 2,614,500 $ 2,299,720 R & D credit 59,250 47,640 Accrued payroll - - Deferred tax liabilites: Depreciation (3,100 ) (7,670 ) Less Valuation Allowance (2,670,650 ) (2,339,690 ) Net deferred tax asset $ - $ -

Summary of Significant Accoun22

Summary of Significant Accounting Policies (Details)	12 Months Ended
	Dec. 31, 2015
Computer equipment [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, Useful lives	5 years
Machinery & equipment [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, Useful lives	10 years

Summary of Significant Accoun23

Summary of Significant Accounting Policies (Details 1) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Summary of Significant Accounting Policies [Abstract]
(Loss) to common shareholders (Numerator)	$ (5,792,118)	$ (3,430,179)
Basic and diluted weighted average number of common shares outstanding (Denominator)	15,599,745	10,411,873

Summary of Significant Accoun24

Summary of Significant Accounting Policies (Details 2) - USD ($)	Dec. 31, 2015	Dec. 31, 2014
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability	$ 7,878,599	$ 3,320,943
Total liabilities measured at fair value	$ 7,878,599	$ 3,320,943
Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability
Total liabilities measured at fair value
Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability
Total liabilities measured at fair value
Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability	$ 7,878,599	$ 3,320,943
Total liabilities measured at fair value	$ 7,878,599	$ 3,320,943

Summary of Significant Accoun25

Summary of Significant Accounting Policies (Details 3) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Beginning balance	$ 3,320,943
Ending balance	7,878,599	$ 3,320,943
Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Beginning balance	3,320,943	361,170
Fair value of derivative liabilities issued	471,144	314,551
Loss on change in derivative liability	4,086,512	2,645,222
Ending balance	$ 7,878,599	$ 3,320,943

Summary of Significant Accoun26

Summary of Significant Accounting Policies (Details Textual) - USD ($)	Sep. 02, 2015	Mar. 24, 2015	Dec. 31, 2015	Dec. 31, 2014
Summary of Significant Accounting Policies (Textual)
Number of options granted			15,950,000
Exercise price			$ 0.23
Depreciation expense			$ 6,772	$ 7,941
Research and development costs			$ 190,565	$ 69,809
Income tax, description			Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority.
Warrant [Member]
Summary of Significant Accounting Policies (Textual)
Antidilutive securities excluded from computation of earnings per share, amount			245,000
Convertible Debt Securities [Member]
Summary of Significant Accounting Policies (Textual)
Antidilutive securities excluded from computation of earnings per share amount, value			$ 1,384,500
Stock Option [Member]
Summary of Significant Accounting Policies (Textual)
Number of options granted	13,500,000	2,450,000
Exercise price	$ 0.26	$ 0.09
Stock options vesting rights		The options will vest 1/25 on a monthly basis starting April 24, 2015 and October 1, 2015, respectively.
Expiration period		7 years
Antidilutive securities excluded from computation of earnings per share, amount			15,978,333

Capital Stock (Details)

Capital Stock (Details) - Capital Stock [Member] - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Capital Stock (Textual)
Common stock issued	6,149,599	2,805,073
Amount of debt conversion	$ 185,500	$ 135,000
Accrued interest	$ 20,648	$ 11,000
Minimum [Member]
Capital Stock (Textual)
Common stock conversion price per share	$ 0.0133	$ 0.0367
Maximum [Member]
Capital Stock (Textual)
Common stock conversion price per share	$ 0.065	$ 0.10

Stock Options and Warrants (Det

Stock Options and Warrants (Details) - $ / shares	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Number of Options
Beginning of period	836,667	836,667
Granted	15,950,000
Exercised
Expired	(808,334)
End of period	15,978,333	836,667
Exercisable at the end of period	2,530,333	811,667
Weighted average exercise price
Beginning of period	$ 1.43	$ 1.43
Granted	$ 0.23
Exercised
Expired	$ 1.45
End of period	0.23	$ 1.43
Exercisable at the end of period	$ 0.21	$ 1.46

Stock Options and Warrants (D29

Stock Options and Warrants (Details 1) - $ / shares	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Stock Options Outstanding	15,978,333	836,667
Stock Options Exercisable	2,530,333	811,667
4.05 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercisable Prices	$ 4.05	$ 4.05
Stock Options Outstanding	3,333	236,667
Stock Options Exercisable	3,333	236,667
Weighted Average Remaining Contractual Life (years)	2 months 23 days	1 year 2 months 23 days
2.92 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercisable Prices	$ 2.92
Stock Options Outstanding	25,000
Stock Options Exercisable	25,000
Weighted Average Remaining Contractual Life (years)	2 years 2 months 1 day
0.09 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercisable Prices	$ 0.09
Stock Options Outstanding	2,450,000
Stock Options Exercisable	882,000
Weighted Average Remaining Contractual Life (years)	6 years 2 months 23 days
0.26 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercisable Prices	$ 0.26
Stock Options Outstanding	13,500,000
Stock Options Exercisable	1,620,000
Weighted Average Remaining Contractual Life (years)	6 years 8 months 5 days
0.40 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercisable Prices		$ 0.40
Stock Options Outstanding		600,000
Stock Options Exercisable		575,000
Weighted Average Remaining Contractual Life (years)		3 years 2 months 1 day

Stock Options and Warrants (D30

Stock Options and Warrants (Details 2)	12 Months Ended
	Dec. 31, 2015
Stock Options and Warrants [Abstract]
Risk free interest rate Minimum	1.68%
Risk free interest rate Maximum	1.92%
Stock volatility factor Minimum	104.37%
Stock volatility factor Maximum	114.97%
Weighted average expected option life	7 years
Expected dividend yield

Stock Options and Warrants (D31

Stock Options and Warrants (Details 3)	12 Months Ended
	Dec. 31, 2015$ / sharesshares
Number of Warrants
Beginning period | shares	245,000
Granted | shares
Exercised | shares
Expired | shares
End of period | shares	245,000
Exercisable at the end of period | shares	245,000
Weighted average exercise price
Beginning of period | $ / shares	$ 0.97
Granted | $ / shares
Exercised | $ / shares
Expired | $ / shares
End of period | $ / shares	$ 0.97
Exercisable at the end of period | $ / shares	$ 0.97

Stock Options and Warrants (D32

Stock Options and Warrants (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Stock Options and Warrants (Textual)
Number of options granted	15,950,000
Stock based compensation	$ 446,296	$ 51,883
Intrinsic value of options outstanding
Warrants outstanding	245,000
Term of warrant	5 years
October 2016 [Member]
Stock Options and Warrants (Textual)
Warrants outstanding	95,000
October 2017 [Member]
Stock Options and Warrants (Textual)
Warrants outstanding	150,000

Convertible Promissory Notes (D

Convertible Promissory Notes (Details) - USD ($)	Apr. 17, 2015	Dec. 18, 2014	Mar. 05, 2014	Dec. 31, 2015	Dec. 31, 2014	Jun. 05, 2013
Convertible Promissory Notes (Textual)
Convertible promissory note principal amount		$ 128,000				$ 242,000
Amortization of debt discount recognized as interest expense during December 31, 2015				$ 432,774	$ 159,874
Proceeds from convertible promissory notes				$ 730,000	$ 500,000
Chief Executive Officer (Member)
Convertible Promissory Notes (Textual)
Convertible promissory note interest, Percentage		5.00%				5.00%
Convertible promissory note principal amount		$ 68,000				$ 114,000
Chief Technology Officer (Member)
Convertible Promissory Notes (Textual)
Convertible promissory note interest, Percentage		5.00%				5.00%
Convertible promissory note principal amount		$ 61,000				$ 128,000
Convertible Debt [Member]
Convertible Promissory Notes (Textual)
Convertible promissory note principal amount	$ 130,000		$ 55,000
Common stock issued	2,187,692
Accrued interest	$ 12,200		2,063
Debt instrument, remaining balance	$ 57,000		$ 187,000
Common stock conversion price per share	$ 0.24	$ 0.101
Maturity date	Jun. 5, 2016
Fair vlue of expected option life	2 years	2 years
Amortization of debt discount recognized as interest expense during December 31, 2015	$ 24,360	$ 47,930
Common stock issued, Shares			694,191
Debt conversion, description	The notes are convertible into shares of common stock of the Company at a conversion price equal to the lesser of $0.24 per share or the closing price per share of common stock recorded on the trading day immediately preceding the date of conversion.	The notes are convertible into shares of common stock of the Company at a conversion price equal to the lesser of a) $0.101 per share of common stock or b) the closing price per share of common stock recorded on the trading day immediately preceding the date of conversion.
Fair value Measurements, valuation techniques	Black-Scholes pricing model	Black-Scholes pricing model

Derivative Liabilities (Details

Derivative Liabilities (Details)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Expected dividend yield
Minimum [Member]
Risk free interest rate	0.00%	0.02%
Stock volatility factor	47.60%	104.46%
Weighted average expected option life	1 month	6 months
Maximum [Member]
Risk free interest rate	0.64%	0.58%
Stock volatility factor	310.40%	149.81%
Weighted average expected option life	2 years	2 years

Derivative Liabilities (Detai35

Derivative Liabilities (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Derivative Liabilities (Textual)
Fair value of the derivative liability	$ 7,878,599	$ 3,320,943
Convertible Debt [Member]
Derivative Liabilities (Textual)
Fair value of the conversion feature	471,144
Amount of debt conversion	185,500
Loss on change in derivative liability	4,086,512
Fair value of the derivative liability	$ 7,878,599	$ 3,320,943

Intangible Assets (Details)

Intangible Assets (Details) - USD ($)	Dec. 31, 2015	Dec. 31, 2014
Intangible Assets (Textual)
Carrying value of patents	$ 70,270	$ 85,830

Income Taxes (Details)

Income Taxes (Details) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Income Taxes [Abstract]
Book income	$ (2,317,510)	$ (1,372,071)
Depreciation	(730)	(420)
Meals and Entertainment	370	350
Non-deductible non-cash charges	$ 1,986,900	1,142,791
Accrued payroll		(14,400)
Valuation Allowance	$ 330,970	$ 243,750
Income tax expense

Income Taxes (Details 1)

Income Taxes (Details 1) - USD ($)	Dec. 31, 2015	Dec. 31, 2014
Deferred tax assets:
NOL Carryover	$ 2,614,500	$ 2,299,720
R & D credit	$ 59,250	$ 47,640
Accrued Payroll
Deferred tax liabilities:
Depreciation	$ (3,100)	$ (7,670)
Less Valuation Allowance	$ (2,670,650)	$ (2,339,690)
Net deferred tax asset

Income Taxes (Details Textual)

Income Taxes (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Income Taxes (Textual)
Operating loss carry-forwards	$ 7,227,000
Tax benefit

Commitments and Litigations (De

Commitments and Litigations (Details) - USD ($)	1 Months Ended	12 Months Ended
	Nov. 30, 2015	Dec. 31, 2015	Dec. 31, 2014
Commitments and Litigations (Textual)
Monthly lease payments		$ 534
Increment on monthly lease payments	$ 550
Rent expense		$ 6,440	$ 6,408

Subsequent Event (Details)

Subsequent Event (Details) - Subsequent Event [Member] - USD ($)	Feb. 09, 2016	Jan. 26, 2016	Jan. 15, 2016	Jan. 11, 2016
Subsequent Event (Textual)
Common stock issued		192,193	660,161
Common stock conversion of principal amount		$ 2,000	$ 7,500
common stock upon conversion of accrued interest		$ 556	$ 1,280
Convertible Promissory Note Agreement [Member]
Subsequent Event (Textual)
Additional consideration on convertible promissory note	$ 87,000			$ 68,000
Convertible notes original principal amount				$ 500,000
Unsecured convertible note description				The Company revised and restated two (2) convertible notes with original principal sums of up $500,000 issued on May 2, 2014 and January 30, 2015, respectively. The maturity date of the notes was extended to eighteen (18) months from the effective date of each payment of consideration, and is the date upon which the principal sum of each Note and unpaid interest and fees shall be due and payable.